PedAM
Pediatric Disease Annotations & Medicines
| Disease | visceral leishmaniasis |
| Phenotype | C0023281|leishmaniasis |
| Sentences | 6 |
| PubMedID- 25874069 | In general, l. guyanensis is the etiological agent for cutaneous leishmaniasis, and no cases of visceral leishmaniasis due to l. guyanensis have been reported in the literature in both hiv negative and hiv positive individuals. |
| PubMedID- 22882665 | Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in bihar, india. |
| PubMedID- 26399545 | This is an endemic for canine leishmaniasis area with several human visceral leishmaniasis cases. |
| PubMedID- 25984144 | Immunocompromised patients, who contract the infection more frequently, may develop post-kala-azar dermal leishmaniasis, a complication of visceral leishmaniasis, which usually presents with a macular or nodular rash that develops after 6 months to 1 year after the systemic disease. |
| PubMedID- 24260115 | Arginase was found to be increased in lesions of patients with cutaneous leishmaniasis [16] and in patients with visceral leishmaniasis and hiv co-infection [15]. |
| PubMedID- 23522098 | Ten patients with different clinical conditions co-infected with tb and leishmaniasis were reported, of which, visceral leishmaniasis was the highest. |
Page: 1